Our Pricing

Weight Loss Injections In Stock UK - Order Today

Published on: June 03, 2026

Finding weight loss injections in stock UK can be challenging during ongoing supply pressures, but Cured Pharmacy maintains reliable availability of Mounjaro, Wegovy, and Saxenda with transparent upfront pricing from £135.00. Our UK-registered clinical team provides free consultations under three minutes, with discreet next-day delivery across the UK once your prescription is approved.

How GLP-1 Weight Loss Injections Work

GLP-1 receptor agonists like semaglutide and tirzepatide mimic natural gut hormones that regulate appetite and blood glucose levels [1]. These injectable medications slow gastric emptying, reduce hunger signals to the brain, and improve insulin sensitivity—creating a physiological environment conducive to sustained weight loss.

Clinical evidence demonstrates significant efficacy: tirzepatide produced average weight reductions of 22.5% over 72 weeks in the SURPASS-3 trial, whilst semaglutide achieved 14.9% reduction in the STEP 1 trial [1][2]. These results represent substantially greater weight loss than diet and exercise alone, though individual outcomes vary based on adherence, lifestyle modifications, and metabolic factors.

Mounjaro (Tirzepatide) - Dual-Action Weight Loss Treatment

Mounjaro represents the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, tirzepatide produces enhanced metabolic effects compared to single-pathway treatments.

Available at Cured Pharmacy from £135.00 Mounjaro is administered once weekly via the convenient KwikPen injection device. Dosing typically begins at 2.5mg and escalates gradually to 5mg, 10mg, or 15mg based on individual tolerance and clinical response [3]. The structured dose escalation minimises gastrointestinal side effects whilst optimising therapeutic benefit.

Who Can Use Mounjaro?

Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above with weight-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Your UK prescriber will assess your medical history, current medications, and contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Wegovy (Semaglutide) - Proven Weight Management Solution

Wegovy contains semaglutide, a GLP-1 receptor agonist extensively studied in the STEP clinical trial programme involving over 4,500 participants [2]. The medication demonstrated consistent weight reduction across diverse patient populations, with 83.5% of participants achieving at least 5% weight loss compared to 31.1% on placebo.

At Cured Pharmacy, Wegovy injections start from £10 offering competitive UK pricing for this MHRA-licensed treatment. The once-weekly injection follows a gradual dose escalation from 0.25mg to a maintenance dose of 2.4mg over 16-20 weeks. We also stock Wegovy oral tablets from £135.00 for patients preferring non-injectable options, though clinical data primarily supports the injectable formulation.

Wegovy Side Effects and Management

Common side effects include nausea, diarrhoea, vomiting, and constipation, typically most pronounced during dose escalation phases [2]. These gastrointestinal effects usually diminish within 4-8 weeks as your body adapts. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can help manage symptoms. Serious but rare risks include pancreatitis, gallbladder disease, and thyroid tumours—your prescriber will discuss warning signs during consultation.

Saxenda (Liraglutide) - Daily Injection Alternative

Saxenda offers a daily injection option for patients who prefer more frequent dosing or have specific clinical considerations favouring liraglutide over weekly alternatives. As a GLP-1 receptor agonist, it operates through similar appetite-suppressing mechanisms but requires daily subcutaneous administration [4].

Available from £135.00 at Cured Pharmacy, Saxenda represents an accessible entry point for GLP-1 therapy. The treatment begins at 0.6mg daily and increases weekly by 0.6mg increments until reaching the maintenance dose of 3.0mg. Clinical trials showed average weight loss of 8% over 56 weeks when combined with reduced-calorie diet and increased physical activity [4].

Weight Loss Injections In Stock UK: Comparing Your Options

Stock availability for weight loss injections has fluctuated across UK pharmacies due to unprecedented demand and manufacturing constraints. At Cured Pharmacy, we maintain robust supply chains for Mounjaro, Wegovy, and Saxenda, with real-time stock status displayed on each product page before you begin your consultation.

Choosing between treatments depends on multiple factors: efficacy data, injection frequency preference, side effect profiles, cost considerations, and individual medical history. Mounjaro typically produces the greatest weight loss but costs more; Wegovy offers strong efficacy with once-weekly convenience; Saxenda provides daily dosing control at a lower price point. Your UK prescriber will recommend the most appropriate option during your free clinical assessment.

Treatment Selection Criteria

Beyond BMI requirements, prescribers consider cardiovascular risk factors, diabetes status, previous weight loss medication history, needle anxiety, budget constraints, and lifestyle factors. Patients with established cardiovascular disease may particularly benefit from semaglutide given cardioprotective effects demonstrated in the SELECT trial [5]. Those seeking maximum weight reduction may be better suited to tirzepatide, whilst cost-conscious patients might prefer Saxenda or oral alternatives like Orlistat.

How to Order Weight Loss Injections from Cured Pharmacy

Our streamlined process ensures you can access treatment quickly whilst maintaining full clinical safety standards. Begin by selecting your preferred treatment and clicking 'Start Assessment' to complete a confidential medical questionnaire reviewed by our UK-registered prescribers (GPhC-registered, overseen by Superintendent Pharmacist Tarun Kumar, GPhC 2233073).

Consultations take under three minutes to complete and incur no charge. If approved, your prescription is dispensed from our GPhC-registered pharmacy (9012511) and dispatched in 100% discreet packaging via next-day delivery. You'll see the exact price before consultation—no hidden fees or surprise charges. All medications are genuine UK-licensed products sourced through regulated pharmaceutical wholesalers.

Ongoing Support and Monitoring

Weight loss injection therapy requires regular monitoring for efficacy and safety. We recommend monthly weight tracking, quarterly clinical reviews, and immediate contact if you experience severe abdominal pain, persistent vomiting, or signs of pancreatitis. Our clinical team remains available via phone (+44 116 4646009) for any questions or concerns throughout your treatment journey. Repeat prescriptions can be ordered through your online account once your initial supply nears completion.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14926 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and physical activity levels.